General Proximity is building the first generalized, mechanism-agnostic, proximity discovery engine. The company focuses on programmable medicines for all mankind, leveraging the concept that proximity is a master regulator of biology.
All biological processes are driven by proximity. General Proximity's platform enables the discovery of powerful proximity mechanisms between target and effector proteins, allowing for precise control over protein function—such as activation, degradation, or re-localization—opening up new therapeutic possibilities for previously undruggable targets.
Their approach taps into the 'effectome,' the set of all proteins that modulate other proteins, to create next-generation proximity therapeutics. By controlling proximity, they aim to control biology in a programmable and scalable way.